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Abstract X-linked hydrocephalus (XLH) is characterized
by increased intracranial ventricle size and head circum-
ference secondary to aqueduct of Sylvius congenital ste-
nosis. Exceedingly rare is the concurrence of XLH and
Hirschsprung’s disease (HSCR) with a theoretical inci-
dence of 1 in 125–250 million cases. Herein, we are
describing a case of a patient with concurrent XLH and
HSCR. The patient was delivered via cesarean section at
37 weeks gestation and underwent uneventful ventriculo-
peritoneal shunt placement. As a part of a workup for
constipation, we performed a rectal biopsy, which was
consistent with HSCR. Genetics testing showed hemizy-
gous for R558X hemizygous mutation in the L1CAM gene.
AC? T nucleotide substitution in exon 13 resulted in
replacement of an arginine codon with a stop codon, a
nonsense mutation. Although it is widely accepted that
HSCR represents the failure of early embryonic neural
crest cells to migrate properly, the exact mechanism is not
known. The association of HSCR with XLH in the pres-
ence of L1CAM mutations remains quite interesting
because cell adhesion molecules are involved in the proper
migration of neural components throughout the body.
Additional studies are necessary to fully elucidate the
relationship between XLH and HSCR in the presence of
L1CAM mutations.
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Introduction
X-linked hydrocephalus (XLH) is characterized by hydro-
cephalus with enlargement of the third and lateral ventri-
cles due to stenosis of the aqueduct of Sylvius. Classical
clinical features include mental retardation, bilateral
adducted thumbs, upper and lower extremity hypotonia
and spasticity, and minor craniofacial abnormalities [1].
Hypoplasia or complete absence of the corpus callosum as
seen on MRI is an associated malformations. XLH is quite
rare, with a frequency between 1:25,000 and 1:50,000.
Exceedingly rare, but clinically signiﬁcant, is the concur-
rence of XLH and HSCR with theoretical incidence of 1 in
125–250 million cases [2, 3]. Notwithstanding, there have
been eight reported cases of XLH in association with
HSCR in the presence of a multiplicity of L1 CAM (L1 cell
adhesion molecule) gene mutations. Herein, we present an
additional case of XLH and HSCR with conﬁrmed L1CAM
mutation.
Case presentation
The patient is the second child born to a G2P2 mother in
good health receiving excellent prenatal care. The patient’s
mother is an only child of European ancestry. The patient’s
S.-R. Jackson  Y. S. Guner  R. Woo  H. Ford 
C. E. Shin (&)
Department of Pediatric Surgery, Children’s Hospital Los
Angeles, Keck School of Medicine, University of Southern
California, 4650 Sunset Boulevard, Mailstop #72, Los Angeles,
CA 90027, USA
e-mail: cshin@chla.usc.edu
Y. S. Guner
e-mail: yguner@chla.usc.edu
L. M. Randolph
Department of Pediatrics, Division of Medical Genetics,
Children’s Hospital Los Angeles, Keck School of Medicine,
University of Southern California, 4650 Sunset Boulevard,
Mailstop #72, Los Angeles, CA 90027, USA
123
Pediatr Surg Int (2009) 25:823–825
DOI 10.1007/s00383-009-2420-0maternal grandmother has one sibling, a healthy brother.
The patient’s father is of Persian and European ancestry.
The patient has a healthy brother. The family history is
otherwise negative for birth defects, mental retardation and
neurological disorders. Consanguinity is denied.
Fetal ultrasound examination in the third trimester
revealed hydrocephalus. The patient was delivered via
cesarean section at 37 weeks gestation and admitted to the
neonatal intensive care unit (NICU) for respiratory support.
He was noted on physical examination to have prominent
hydrocephalus, global hypotonia and spastic paresis of
bilateral lower extremities. Bilateral thumbs were adduc-
ted. On day 4 of life he underwent uneventful ventriculo-
peritoneal shunt placement. The patient could not be
sustained on oral nutrition and was maintained on naso-
gastric feedings for nutritional support. Moreover, as a part
of a workup for severe constipation requiring periodic
enemas dating back to birth, a rectal biopsy was performed.
The biopsy results were consistent with Hirschsprung’s
disease as demonstrated by the absence of ganglion cells
and hypertrophy of nerve ﬁbers with enhanced acetyl
cholinesterase activity. He was discharged from the NICU
on day of life 30 and shortly thereafter did tolerate gas-
trostomy tube placement at month 2 of life. The family was
anxious to take the child home and felt comfortable to
perform rectal irrigations. The child was allowed to recu-
perate and grow for an additional 10 months after which he
underwent aganglionic bowel resection with rectosigmoid
(Soave) pull-through and diverting ileostomy. In the
immediate postoperative period, the patient exhibited new
onset seizure activity that responded rapidly to intravenous
barbiturate. As per neurology recommendations the child
was not maintained on this anti-seizure medication. The
remainder of the postoperative period proceeded without
event and the child was discharged to home. The patient is
now tolerating consolidated gastric tube feeding. Following
discharge, he was seen by ophthalmology for nonreactive
and asymmetrical pupils suggesting optic nerve hypoplasia,
a condition which is deﬁned as a congenital deﬁciency of
retinal ganglion cells [4]. This suspected deﬁciency of
retinal ganglion cells is particularly interesting in a patient
with HSCR who demonstrates rectal absence of ganglion
cells. The child did receive vision therapy, but has since
stopped and is tracking well with normal focusing.
Additional workup
Geneticsconsultation was obtained.The patient wasfound to
behemizygousforR558XmutationintheL1CAMgene.This
is indicative of a C ? T nucleotide substitution in exon 13,
resulting in the replacement of an arginine codon with a stop
codon at amino acid position 558. This creates a nonsense
mutation that is predicted to cause loss of normal protein
function either through premature protein truncation or
through nonsense-mediated mRNA decay. The patient’s
mother declined DNA carrier testing for personal reasons.
Discussion
Previous reports have described instances of XLH sec-
ondary to stenosis of the aqueduct of Sylvius [5–8]. XLH is
associated with any of a number of largely private muta-
tions of the L1CAM gene, with more than 180 mutations
reported to date [9, 10]. L1CAM, or neural cell adhesion
molecule 1, is a member of the immunoglobulin super
family of cell adhesion molecules expressed widely in
developing neurons [11]. The gene is located on chromo-
some Xq28, and the condition is inherited in an X-linked
recessive pattern, with a minority of cases representing new
mutations. Some genotype–phenotype correlations are
possible, as mutations affecting different regions of the
gene, and therefore the protein, are classiﬁed as to their
type with loose correlations as to their clinical signiﬁcance.
Within a family, however, two individuals with the same
mutation might have a different degree of severity, so other
factors are clearly responsible for part of the clinical pre-
sentation. Mutations affecting different regions of the
protein will have different effects and have been classiﬁed
accordingly [12]. Class I L1CAM mutations affect the
cytoplasmic domain, while class II mutations are missense
point mutations or deletions affecting the extracellular
domain. Class III mutations are nonsense mutations leading
to premature stop codons with truncation of the extracel-
lular domain which are the most severe L1CAM defects.
The patient described in the report has a class III mutation.
With this report, we add to the literature with an addi-
tional case report of a patient with XLH and HCSR with an
L1CAM mutation [1, 2, 13]. Although it is widely accepted
that HSCR represents the failure of early embryonic neural
crest cells to migrate properly, the exact mechanism is not
known. Defects in many genes have been implicated in
HSCR, including RET proto-oncogene, endothelin receptor
b, endothelin-3, SOX-10, and SIP1 [1] and L1CAM
mutations alone certainly do not account for HSCR. Even
so, the association of HSCR with XLH in the presence of
L1CAM mutations remains quite interesting because cell
adhesion molecules are involved in the proper migration of
neural components throughout the body. Perhaps, L1CAM
acting as an X-linked modiﬁer gene somehow allows for
the manifestation of additional errors in genes known to be
associated with HSCR [14]. While L1CAM mutation in the
presence of XLH cannot independently predict HSCR, the
multidisciplinary medical and surgical teams should pro-
actively rule out the diagnosis of HSCR in the child with
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123signs of feeding intolerance, vomiting, constipation or
abdominal distention. A barium enema can quickly identify
the presence of a small colon as well as rectal caliber change.
Surgical consultation for suction or open rectal biopsy with
acetylcholinesteraseactivitylevelassayshouldbeperformed
to conﬁrm the diagnosis of HCSR. The goal of staged sur-
gical intervention is to remove the aganglionic bowel seg-
ment with anastomosis of normal proximal bowel to rectal
tissue just above the anus coupled with a diverting ostomy to
allow healing of the fresh suture line. This ostomy is later
reversed to re-establish bowel continuity. While it is obvious
thatadditionalstudiesare necessarytofullyelucidate thetrue
relationship between XLH and HSCR in the presence of
L1CAM mutations, we are compelled to recognize the
association in an effort to optimize outcomes in this rare, but
all too often fragile patient population (Figs. 1, 2).
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Fig. 1 Plain radiograph demonstrating multiple, dilated loops of
bowel
Fig. 2 Barium enema demonstrating proximal dilated bowel with
collapsed distal segment
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